Skip to main content

Table 11 Incidences of any DVT (up to POD10) and major bleeding (up to POD28) in propensity-matched fondaparinux- or enoxaparin-treated groups (TKA)

From: Venous thromboembolism after total joint arthroplasty: results from a Japanese multicenter cohort study

Events

Fondaparinux

Enoxaparin

Risk ratio (95% CI)

P value

n = 204

n = 204

DVT

28/204 (13.6%)

54/204 (26.2%)

0.70 (0.58-0.85)

0.002

Major bleeding

7/204 (3.4%)

1/204 (0.5%)

4.18 (0.67-26.20)

0.062

  1. CI, confidence interval; DVT, deep vein thrombosis; POD, postoperative day; TKA, total knee arthroplasty.